fund
Artemis Global Select I
Global equity fund with stock selection feeding off long term trends identified by the managers.
-
149.21p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
175.00p
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
1.00% 0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
0.75%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
0.90%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
0.90%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
The objective of the Fund is to achieve long term capital growth primarily from a portfolio of global equities that the Manager considers to demonstrate leading positions in their sectors.
Fund summary
| Sector | Global |
| Structure | UNIT TRUST |
| Launched | June, 2011 |
| Size | £0m |
| Yield | 0.90% |
| Charging basis | Income |
| Dividends paid | June. |
Charges
| Standard initial charge | 1.00% |
| Initial charge via Bestinvest | 0.00% |
| Additional bid/offer spread | 0.00% |
| Annual management charge | 0.75% |
| Ongoing charges figure | 0.90% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
Manager research
Average monthly relative returns
- 16/17 -0.11%
- 17/18 0.13%
- 18/19 0.18%
- 19/20 0.05%
- 20/21 -0.01%
Bestinvest MRI
- 3 years 0.07%
- 5 years 0.04%
- Career 0.01%
- 3 years 72.20%
- 5 years 76.70%
- Career 80.50%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Simon Edelsten / Alex Illingworth
Edelsten joined Artemis from Taube Hodson Stonex, where he had been since 2001. Before this he was at Dresdner Kleinwort Benson (1997-2001) as Head of European Equity Sales and took special responsibility for their Telecommunications team. He came into the City in 1984 and worked for Philips & Drew and then BZW from 1986-1997. Edelsten graduated from Trinity College Oxford in 1983. Illingworth joined Artemis from Insight Investment where he was Director of global equity. Illingworth joined the Global Equity Funds team at Insight as a director April 2003, moving across from Rothschild Asset Management (RAM) following its acquisition. He joined the International Equities department at RAM in 1997. Having started by looking at emerging markets his role was expanded to work on the global funds with an emphasis on stock selection. Illingworth holds a BA (Hons) in Combined Social Sciences from Durham University. He completed the IIMR examinations in June 1999 and is a member of AIMR.
Track record
Simon Edelsten / Alex Illingworth has 10.2 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.01%. During the worst period of relative performance (from September 2011 - August 2014) there was a decline of 11% relative to the index. The worst absolute loss has been 13%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 81%.
Periods of worst performance
| Absolute | -13.00% (August 2018 - December 2018) |
| Relative | -11.00% (September 2011 - August 2014) |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Top 10 holdings
Data accurate as at 30 July 2021
| 2.6363% | Thermo Fisher Scientific Inc |
| 2.6303% | Alphabet Inc |
| 2.4572% | Equinix Inc |
| 2.2978% | Unitedhealth Group Inc |
| 2.2241% | Anthem Inc |
| 2.1362% | Prologis Inc |
| 2.0816% | Trane Technologies Plc |
| 2.0436% | Boston Scientific Corp |
| 2.0312% | Perkinelmer Inc |
| 1.9907% | Avery Dennison Corp |
| Source: Trustnet |
Sector breakdown
| Software | 15.00% |
| Biotechnology/Medical | 15.00% |
| Capital Goods | 9.00% |
| Healthcare & Medical Products | 8.00% |
| Materials | 7.00% |
| Hardware | 6.00% |
| Real Estate | 5.00% |
| Media | 5.00% |
| Transport | 5.00% |
| Money Market | 5.00% |